David Krempa | Senior Vice President, Business Development & Investor Relations |
Sean Brynjelsen | Chief Executive Officer |
James Gruber | Chief Financial Officer |
Good afternoon and welcome to the Eton Pharmaceuticals' Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen only mode.
Following the formal remarks, we will open the call out for your question. Please be advised that this call is being recorded at the company's request. At this time, I would like to turn it over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals.